REVITOPE

Revitope Oncology is a biotech company leveraging biological insights and protein engineering to develop a new class of cancer immunotherapies powered for precision... Revitope Oncology, Inc. is a privately funded cancer therapeutics company with a focus on innovative tumor-specific antibody-based T cell engager immunotherapies. Based in Cambridge, MA, the company has conceived, engineered, patented and pre-clinically tested novel classes of bispecific antibody therapeutics designed to enable tumor-specific immunotherapy with improved therapeutic efficacy and safety.

Also known as: Revitope Limited, Revitope Oncology, Revitope Oncology, Inc.

Primary location: Concord United States